I think it has no bearing on contract for film application.
I think it has no bearing on contract for film application. This is for on-chip QD-LED and backlight application.
I also think they probably exceeded the 1,000 hours well before the Aug. 5 date where he mentioned it on LinkedIn.
As for next step technical breakthroughs, I would think we'll hear about the following over the next year:
1) blue qdot performance improvements
2) QD-LED and backlight application testing (3,000 hour, and beyond)
3) Potentially info on solar cell R&D initiatives or performance improvements
Who knows what breakthroughs they may have! When you can do 100s of separate qdot configuration tests per day with their reactor technology, the possibilities are relatively endless.
With respect to next PR or newsletter, Squires stated he would update us soon on the qdot film status. I'm assuming when he says soon that we'll see something next week or the following with respect to a PR or newsletter.
Quantum Materials Corp. (QTMM) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding Pet Anxiety: Trends and Tips Trupanion, Inc. (Nasdaq: TRUP) reports a notable increase in anxiety claims for pets. An examination of veterinary invoice data from over one million insured pets reveals that 2023 has marked a record high in both the total number of anxiety claims and the average number of claims per pet. It's important for pet owners to...
Continue Reading
Important Information About Man Group PLC's Disclosure Man Group PLC has made a significant disclosure regarding its stake in Centamin plc, a company active in the mining and resource sector. These disclosures are key for grasping market dynamics and understanding how investors feel about the current landscape. Understanding the Disclosure Requirements This disclosure...
Continue Reading
Overview of Vivoryon Therapeutics Financial Results Vivoryon Therapeutics N.V. is pleased to share an insightful overview of its fiscal performance and strategic developments relating to its commitment toward innovative treatments, especially in the field of kidney disease. The company, specializing in small molecule medicines that modulate altered proteins, is making...
Continue Reading
SS Innovations Sets New Standards in Robotic Surgery SS Innovations International, Inc. (OTC: SSII) has embarked on a remarkable journey to reshape the landscape of robotic surgery. With its award-winning SSi Mantra surgical robotic system successfully completing over 3,500 surgeries, the company continues to champion innovation, making advanced surgical technology...
Continue Reading
Aspen One Strengthens Its Artistic Commitment Aspen One has announced a renewed dedication to art programming across its diverse portfolio, enhancing its long-standing Art in Unexpected Places initiative. This investment reaffirms the company’s commitment to supporting arts and artists, a fundamental aspect of its identity and community engagement. With a rich legacy of...
Continue Reading